Published in:
Open Access
01-12-2014 | Research
New GOLD classification: longitudinal data on group assignment
Authors:
Ciro Casanova, Jose M Marin, Cristina Martinez-Gonzalez, Pilar de Lucas-Ramos, Isabel Mir-Viladrich, Borja Cosio, German Peces-Barba, Miryam Calle-Rubio, Ingrid Solanes-García, Ramón Agüero, Alfredo de Diego-Damia, Nuria Feu-Collado, Inmaculada Alfageme, Rosa Irigaray, Eva Balcells, Antonia Llunell, Juan Bautista Galdiz, Margarita Marín, Juan José Soler-Cataluña, Jose Luis Lopez-Campos, Joan B Soriano, Juan P de-Torres, for the COPD History Assessment In SpaiN (CHAIN) cohort
Published in:
Respiratory Research
|
Issue 1/2014
Login to get access
Abstract
Rationale
Little is known about the longitudinal changes associated with using the 2013 update of the multidimensional GOLD strategy for chronic obstructive pulmonary disease (COPD).
Objective
To determine the COPD patient distribution of the new GOLD proposal and evaluate how this classification changes over one year compared with the previous GOLD staging based on spirometry only.
Methods
We analyzed data from the CHAIN study, a multicenter observational Spanish cohort of COPD patients who are monitored annually. Categories were defined according to the proposed GOLD: FEV1%, mMRC dyspnea, COPD Assessment Test (CAT), Clinical COPD Questionnaire (CCQ), and exacerbations-hospitalizations. One-year follow-up information was available for all variables except CCQ data.
Results
At baseline, 828 stable COPD patients were evaluated. On the basis of mMRC dyspnea versus CAT, the patients were distributed as follows: 38.2% vs. 27.2% in group A, 17.6% vs. 28.3% in group B, 15.8% vs. 12.9% in group C, and 28.4% vs. 31.6% in group D. Information was available for 526 patients at one year: 64.2% of patients remained in the same group but groups C and D show different degrees of variability. The annual progression by group was mainly associated with one-year changes in CAT scores (RR, 1.138; 95%CI: 1.074-1.206) and BODE index values (RR, 2.012; 95%CI: 1.487-2.722).
Conclusions
In the new GOLD grading classification, the type of tool used to determine the level of symptoms can substantially alter the group assignment. A change in category after one year was associated with longitudinal changes in the CAT and BODE index.